好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Using the Selective Inhibitor of Nuclear Export (SINE) Compound KPT-350 to Reduce Cortical Circuit Hyperexcitability and Interneuron Cell Loss in the Controlled Cortical Impact (CCI) Model of Traumatic Brain Injury (TBI)
Epilepsy/Clinical Neurophysiology (EEG)
(-)
001
Authors/Disclosures
David Cantu, PhD (Sunovion Pharmaceuticals Inc.)
PRESENTER
Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
No disclosure on file
Sharon Tamir No disclosure on file
No disclosure on file
No disclosure on file